Background Among those with injection drug use-associated infective endocarditis (IDU-IE),
against medical advice (AMA) discharge is common and linked to adverse outcomes …

Background The incidence of infective endocarditis (IE) and other systemic bacterial
infections is increasing, and people who inject drugs (PWID) have higher rates of discharge …

Background: Rising rates of hospitalization for infective endocarditis (IE) have been
increasingly tied to rising injection drug use (IDU) associated with the opioid epidemic …

Background Injection drug use (IDU) is a major risk factor for infective endocarditis (IE). Few
data exist on repeat IE (rIE) in persons who inject drugs (PWID). Methods Patients≥ 18 …

Background Hospitalizations for individuals with injection drug use-related infective
endocarditis (IDU-IE) represent an increasing portion of all patients with endocarditis. This …

Importance People who inject drugs (PWID) who are being treated for infective endocarditis
remain at risk of new bloodstream infections (BSIs) due to ongoing intravenous drug use …

Abstract Background No International Classification of Diseases, 10th revision (ICD-10),
diagnosis code exists for injection drug use–associated infective endocarditis (IDU-IE) …

Background Injection drug use (IDU) is a growing public health threat in Virginia, though
there is limited knowledge of related morbidity. The purpose of this study was to describe the …

Serious bacterial and fungal infections such as infective endocarditis (IE) are among the
most common medical complications in persons who inject drugs (PWID). 1–3 IE once …

Background Infective endocarditis (IE) in people who inject drugs (PWID) is an emergent
public health problem. Objectives The purpose of this study was to investigate IE in PWID …